From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast - explaining to our in house Bulletin Board moron why taking part in a placing is not insider dealing

By Tom Winnifrith | Monday 25 June 2018


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I look at why taking part in the Premaitha (NIPT) placing did not constitute insider dealing but make a suggestion as to how to change the way AIM placings take part. I look at what the Countrywide (CWD) statement means for Purplebricks (PURP) and at UK housing activity, at MySquar (FRAUD) where SP Angel continues to turn a blind eye to crime, at Avanti Communications (AVN), R4E (R4E) and at a new NEX float Tectonic Gold (TTAU) formerly Stratmin and why AIM turned it down and what message that sends to flip flop Ben Turney and Teathers (TEA). Read about my extreme weekend suffering and be generous HERE

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 09:01:30